5Centers for Disease Control and Prevent:Prevention of pneumococcal diseases:Recommendations of the advisory committee on immunization practices[N].MMWR 1997,46(RR-8):1-24.
6Fedson D.WHO recommendation on pneumococcal vaccination:Immunization of elderly people with polyvalent pneumococcal vaccine[J].Infection,1989,17(6):437-441.
7German Federal Institute of Infectious Disease and Noncommunicable Diseases:Recommendations of the permanent vaccination commission of the Robert Koch Institute (STIKO)/Status[N] Epidemiologisches Bulletin 2000,2:9-20.
8Health Canada:Pneumococcal vaccine,in Canadian immunization guide(5th ed.),Minister of public works and government services[S].1998,140-143.
9Nichol KL.The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease[J].Vaccine,1999,17 (suppl 1)S9-1S93.
10Jay C.Pneumococcal polysaccharide vaccine efficacy:An evalution of current recommendation[J].JAMA,1993,270(15):1926-1831.
二级参考文献5
1史久华,徐冰,译.免疫接种安全性监测.北京:人民卫生出版社,2000.33-34.
2Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA, 1999,281 (3) :243-248.
3KAYHTY H , ESKOLA J. New vaccines for the prevention ofpneumococcal infections [ J ]. Emerg Infect Dis, 1996 ,2 (4):289 -298.
4SPANJAARD L, VANDER ENDE A.RUMKE H,e( al. van Al-phen. Epidemiology of meningitis and bacteraemia due to Strepto-coccus pneumoniae in The Netherlands[ J]. Acta Paediatr Suppl,2000,89(435) :22 -26.
5GRAY BM,TURNER ME,DILLON HC JR. Epidemiologic stud-ies Streptococcus pneumoniae in infants. The effects of season andage on pneumococcal acquisition and carriage in the first 24months of life[ J]. Am J Epidemiol,1982,116(4) :692 - 703.
6LEE CJ, WANG TR. Pneumococcal infection and immunizationin children[ J]. Crit Rev Microbiol,1994 ,20(1) :1 -12.
7BORGANO JM, MCLEAN AA,VELLA PP,ei al. Davidson.Vaccination and revaccination with polyvalent pneumococcal poly-saccharide vaccines in adults and infants [ J ]. Proc Soc Exp Biol,1978,157(1) :148 - 154.
8SKOVSTED IC,KERRN MB, SONNE-HANSEN J,et al. Purifi-cation and structure characterization of the active component inthe pneumococcal 22 F polysaccharide capsule used for adsorptionin pneumococcal enzyme-linked immunosorbent assays [ J ]. Vac-cine ,2007 ,25 (35 ) :6490 -6500.
9MACLEOD CM, HODGES RG, HEIDELBERGER al. Pre-vention of pneumococcal pneumonia by immunization with specificcapsular polysaccarides[ S]. J Exp Med, 1945,82(6): 445 -465.
10KARLSSON C,JANSSON PE,SORENSEN UBS. The pneumococ-cal common antigen C-polysaccharide occurs in different forms.Mono-substituted or disubstitued with phosphocholine [ J ]. Eur JBiochem,1999,265 (3) :1091 -1097.
